Recombinant CGA antibody (full length)
Quick Overview for Recombinant CGA antibody (full length) (ABIN7878306)
Target
See all CGA AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- full length
-
Purpose
- Recombinant CgA Antibody / Chromogranin A (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human Chromogranin A protein was used as the immunogen for the recombinant CgA antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
- Optimal dilution of the recombinant CgA antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the recombinant CgA antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- CGA (Glycoprotein Hormones, alpha Polypeptide (CGA))
-
Alternative Name
- CgA
-
Background
- Chromogranin A is present in neuroendocrine cells throughout the body, including the neuroendocrine cells of the large and small intestine, adrenal medulla and pancreatic islets. It is an excellent marker for carcinoid tumors, pheochromocytomas, paragangliomas, and other neuroendocrine tumors. Co-expression of chromogranin A and neuron specific enolase (NSE) is common in neuroendocrine neoplasms. Reportedly, co-expression of certain keratins and chromogranin indicates neuroendocrine lineage. The presence of strong anti-chromogranin staining and absence of anti-keratin staining should raise the possibility of paraganglioma. The co-expression of chromogranin and NSE is typical of neuroendocrine neoplasms. Most pituitary adenomas and prolactinomas readily express chromogranin.
-
UniProt
- P10645
-
Pathways
- Metabolism of Steroid Hormones and Vitamin D, Thyroid Hormone Synthesis, Hormone Transport, Peptide Hormone Metabolism
Target
-